- Lobbying by The Biosimilars Forum
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
|Christopher DeLacy||Counsel, House Science Cmte., Technology Subcmte. Counsel, Senator John Warner|
|Paul Bock||Chief of Staff, Senator Herb Kohl Counsel, House Judiciary Committee|
|Kathyrn Lehman||Chief Counsel, Sbcmte. on Constitution, H. Judiciary Cmte.|
|Kathryn Lehman||Special Assistant to Speaker of the House Policy Director, House Majority Whip Director of Coalition Outreach, Speaker of House Chief of Staff, House Republican Conference|
|Karl Koch||Chief of Staff, Rep. Jim Davis|
|Matthew Banfield||Staff Assistant, Senator Tim Kaine|
|Kerry Feehery||Staff Asst., Special Asst., Dep. Press Sec., Sen. Connie Mac Press Secretary, Joint Economic Committee Policy Analyst, Senate Budget Committee Communications Director, Sen. Mel Martinez Director, State Office of Sen. George LeMieux Chief of Staff, Sen. George LeMieux|
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate